PAWR Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Pro-apoptopic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappa-B transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1.
Synonyms
2310001G03Rik ; PAR 4 ; PAR-4 ; Pawr ; PAWR_HUMAN ; PRKC Apoptosis WT1 Regulator ; PRKC apoptosis WT1 regulator protein ; Prostate apoptosis response 4 protein ; Prostate apoptosis response protein 4 ; prostate apoptosis response protein PAR-4 ; Transcriptional repressor Par-4-like protein PAWR ; Transcriptional repressor PAR4 ; WT1 Interacting Protein
Gene ID
Q96IZ0
Swiss Prot
5074
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
101-200/340
Target
PAWR
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human PAWR
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
Q96IZ0
Predicted Cross Reactivity
Rat, Cow, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items